Navigation Links
BioTrends Releases Fourth Annual Nephrology TreatmentTrends Publication Highlighting Market Trends for Renal Anemia, Hyperphosphatemia, and Secondary Hyperparathyroidism
Date:1/28/2008

EXTON, Pa., Jan. 28 /PRNewswire/ -- BioTrends Research Group, Inc. released its Fourth Annual Nephrology TreatmentTrends Publication, a syndicated report offering comprehensive insight into the management of renal anemia and bone and mineral metabolism in Chronic Kidney Disease (CKD). The report is based on responses to an online survey, completed by 305 clinical nephrologists in the US, during December 2007.

In the anemia market, the vast majority of nephrologists report being aware of safety concerns surrounding the use of ESAs and 80% indicate that these safety issues have had an impact on their management of anemia, primarily reflected in their lower hemoglobin targets. More than three quarters of the nephrologists state that they do not anticipate any further changes. Amgen's Epogen continues its position as market share leader in dialysis while Aranesp and Procrit continue to battle for market leader position in pre-dialysis.

In the IV Iron market, use continues to be primarily reserved for hemodialysis patients with the majority of nephrologists viewing American Regent's Venofer and Watson's Ferrlecit as interchangeable. AMAG Pharmaceuticals recently filed an NDA for a new form of intravenous iron, ferumoxytol, which could be commercially available in the second half of 2008. Current familiarity with ferumoxytol is low, with 68% indicating that they are "not at all familiar" with the product.

In the phosphate binder market, nephrologists seem to be in agreement about the importance of controlling phosphorus in pre-dialysis patients, with 62% reporting "phosphorus" as the most important level to keep within target range (over PTH and calcium). This has not, however, translated into increased use of binders over the past year. Binder preference also remains similar to last year with calcium-based binders (such as Fresenius Medical Care's PhosLo) dominating 2:1 in the pre-dialysis setting, whereas in the dialysis market, the shift to
'/>"/>

SOURCE BioTrends Research Group, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related biology technology :

1. Vital Images Releases Next Generation Enterprise-Wide Solutions Featuring Vitrea(R) 4.0 and ViTALConnect(R) 4.1
2. Quigley Corporation Releases Update on Quigley Pharmas Phase IIb Clinical Study of QR-333 in Diabetic Peripheral Neuropathy
3. Boston Scientific Releases Remote Monitoring Data from its Wireless LATITUDE(R) Patient Management System
4. ARUP Laboratories Releases ARUP Consult(R) 2.0
5. Rabobank Releases Annual North American Food & Agribusiness Outlook
6. National Nanotechnology Initiative releases new strategic plan
7. Seven Summits Research Releases Alerts on XOM, MER, DRYS, CSC, and PDLI
8. CellCyte Genetics Corp. Responds to Plaintiff Law Firm Press Releases
9. Memry Corporation Announces Preliminary Fiscal Fourth Quarter and 2007 Revenue
10. ThermoGenesis Corp. to Announce Fourth Quarter and Year End Results for Fiscal Year 2007 on September 12, 2007
11. Dynatronics to Release Fourth Quarter and Year-end Results Friday, September 14, 2007; Conference Call set for 1:00 p.m. ET
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/3/2008)...nhua-- Huifeng,Bio-Pharmace..., a leading,developer and producer of plant extrac...rmaceutical, nutraceutical and food production in ...n will be made available via,Standard & Poor,s Mar...rvice that enables subscribing publicly traded com...
(Date:7/3/2008)...- AMDL, Inc. (Amex:,ADL), a...rtered in Tustin,Ca., with operations in Shenzhen...s released its investor presentation which is avai...p://www.amdl.com ., About AMDL:, AMDL, Inc. is a...any is,headquartered in Tustin, California with op...
(Date:7/2/2008)...pany to offer choice of two distinct drugs on ... NATICK, Mass., July 2 /- ...announced that the U.S. Food and Drug,Administrati...uting,Coronary Stent System for the treatment of c...ate-labeled XIENCE(TM) V Everolimus-Eluting Corona...
(Date:7/2/2008)... /- Biopure Corporation,(Na...n agreement with,purchasers for a private placemen...million in tranches, assuming no exercise of the w...ds for working capital and general,corporate purpo...and,subsequent closings are subject to conditions ...
Breaking Biology Technology:Huifeng Bio-Pharmaceutical (HFGB) Information to Be Available Through Standard & Poor's Market Access Program 2AMDL Announces Investor Relations Presentation Available on Website 2Boston Scientific Announces FDA Approval for PROMUS(TM) Everolimus-Eluting Coronary Stent System 2Boston Scientific Announces FDA Approval for PROMUS(TM) Everolimus-Eluting Coronary Stent System 3Boston Scientific Announces FDA Approval for PROMUS(TM) Everolimus-Eluting Coronary Stent System 4Biopure Announces Private Equity Financing 2Biopure Announces Private Equity Financing 3
...ere am I? ,What is this? ,Why did they call it tha...s to your companys Web site had better not have to...cording to ,Patrick Bieser, founder of Northwood... self-explanatory, Bieser said. They (users) shoul...November meeting of eInnovate, the networking grou...
... technology job seekers. Its also for all Midweste...ard on job seekers here? Because so many of us are...More than that, it,s because theres so much to say...ng. So many things to know. So many angles to try....to scotch your chances for your next great job, so...
...otonics announced today that TDS Metrocom selected...ngth platforms to deliver new Ethernet services to...ervice, called MegaDATA and GigaDATA will offer ma...le applications. , ,According to Ben Goth, manager...des a managed Ethernet service to meet the market ...
...U.S. Patent and Trade Office issued U.S. Patent No...olymerase and Uses Thereof to the Wisconsin Alumn...cy of the University of Wisconsin-Madison. ConjuG...llectual property invented by its co-founder Richa... research group, which included ConjuGon scientist...
Other Biology Technology:How Usable is Your Web Site? 2Its Your Midwest Technology Wake, Stupid 2Its Your Midwest Technology Wake, Stupid 3
(Date:7/2/2008)...a, July 2, 2008 Volunteers representing the Juven...RF), the American Diabetes Association (ADA) and t...t Senator Byron Dorgan with the 2008 Congressional...the Special Diabetes Program (SDP) in Congress. T...i Room at the Hilton Garden Inn in Grand Forks. ...
(Date:7/2/2008)...ble in Spanish . , Most of the functions perfo...een proteins, which recognise their binding partne...rface. There are many kinds of interactions; howev...tive of structural biology are those which are tra...rs through a large section of the protein surface-...
(Date:7/2/2008)...rcial flower and plant growers know all too well t...wering the value and deterring healthy growth of p...mmercial nursery owners resort to the expensive pr...Some growers use herbicides, but efficacy of herbi...pecies produced in nurseries, and many herbicides ...
(Date:7/1/2008)... from Kettering Police Department Streamlines ...LL, N.J., July 1 /PRNewswire-FirstCall/ -- BIO-key... leader in finger-based biometric,identification a... from the,Kettering, Ohio Police Department for Mo...ed services. With this award, officers on patrol w...
Breaking Biology News(10 mins):Sen. Byron Dorgan to be honored 2Scientists reveal the key mechanisms for affinity between transient binding proteins 2Ethanol byproduct produces green results 2Ohio Law Enforcement Agency Deploys BIO-key(R) Mobile Reporting Software 2Ohio Law Enforcement Agency Deploys BIO-key(R) Mobile Reporting Software 3Human Genome Sciences Invites Investors to Listen to Webcast of Presentation at Bear Stearns Conference 427 1Theater Classes Help Docs Bedside Manners 744 1Theater Classes Help Docs Bedside Manners 744 2Theater Classes Help Docs Bedside Manners 744 3AGI Dermatics President to be Keynote Speaker at the 11th Annual Sunscreen Symposium 426 1AGI Dermatics President to be Keynote Speaker at the 11th Annual Sunscreen Symposium 426 2Arius Features Preclinical Data on Antibody Candidates at Two Conferences 424 1Arius Features Preclinical Data on Antibody Candidates at Two Conferences 424 2Arius Features Preclinical Data on Antibody Candidates at Two Conferences 424 3
... team of scientists has used gene therapy in two s...ormal movements in monkeys and rats with a drug-in..., detailed online in the scientific publications B...describes one strategy to halt Parkinson,s disease...vastating side effects that occur when treating th...
... laboratory work studying how animals evolve, rese...ull out the fishing net and go learn how their the...nford University School of Medicine study publishe...is more predictable than lab experiments suggest. ...k, nature took advantage of the same genetic trick...
...based at Massachusetts General Hospital (MGH) has ...f RNA interference (RNAi), a powerful new research... They used the RNAi process itself to find new gen...m, which someday may help to fight human disease. ...is receiving early online release on the Science E...
... lives in the human gut adaptively shifts more tha...ost,s diet changes from sugar to complex carbohydr...he bacterial species to survive rapidly changing n...ctions and stability of the gut,s highly complex m...ington University School of Medicine in St. Louis....
Other Biology News:Gene Therapy For Parkinson's Disease Moves Forward In Animals 2Gene Therapy For Parkinson's Disease Moves Forward In Animals 3Gene Therapy For Parkinson's Disease Moves Forward In Animals 4Same mutation aided evolution in many fish species, Stanford study finds 2Same mutation aided evolution in many fish species, Stanford study finds 3Scientists identify genetic pathways essential to RNA interference 2Highly adaptable genome in gut bacterium key to intestinal health 2Highly adaptable genome in gut bacterium key to intestinal health 3
The Beacon 2000 Fluorescence Polarization System is an ideal tool for basic research and assay development. Standard Beacon 2000 System: The Standard Beacon 2000 System uses a quartz-halogen lamp th
The bench-top stand comfortably holds up to 6 Finnpipette Digital single- and multichannel pipettes. The crossbars are made of a grippy material to keep the pipettes firmly in place. Individual shelf
Preparation Note: Prepared essentially by method of Singer, T.P., J. Biol. Chem., 174, 11 (1948). Quality Clarifier: Contains lipase Unit Definition: One unit will hydrolyze 1.0 μmole of p-ni
...serine/threonine phosphatase isolated from human r...of 60kDa (A) and 36kDa (C) subunits. It has the ab...ylase kinase. With its 3638kDa catalytic subunit, ...lay a regulatory role in DNA replication, transcri...
Biology Products: